11d agoStocktwits NewsBULLISH 68Earnings
Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
Pfizer gained on vaccine and oncology growth, MiniMed on strong earnings, and Deere on AI-driven agriculture.
Archived explainer. For the current picture see today's MMED page.
Why Is MINIMED GROUP INC (MMED) Stock Up Today?
By the Top Tier Newswire AI Desk · September 2, 2026 at 12:07 AM ET · reviewed against 16 wire stories
MINIMED GROUP INC (MMED) is up +10.66% in the latest session. Our newswire has captured 16 stories on MMED across 9 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
MiniMed Group Inc (MMED) surged 10.66% to $22.42 in morning trading on September 1, 2026. The move followed a strong first-quarter performance and upgraded analyst expectations. The stock hit a new 52-week high, driven by a raised fiscal 2027 revenue growth outlook and a price target increase from Wells Fargo.
What Happened
MiniMed reported first-quarter net sales of $843 million, a 16.6% increase year-over-year. The company raised its fiscal 2027 organic revenue growth guidance to approximately 10.5%, citing momentum from the launch of its Flex product and progress toward a U.S. launch of Fit by summer 2027. The CEO described the quarter as an excellent start to the fiscal year and emphasized the company's positioning to accelerate growth. On the same day, Wells Fargo raised its price target for MiniMed to $26 from $22, while BTIG also increased its price target and maintained a "Buy" rating. The stock’s upward momentum was further supported by positive retail trader sentiment and a recent 510(k) filing for Fit.
What The Data Shows
Over the last eight trading sessions, MMED has gained 10.4%, rising from $20.18 to $22.27. The stock closed Monday at $20.88, just below its 52-week high of $20.88, and now trades at $22.42. The company’s revenue has grown 14.3% in the trailing twelve months, but it remains unprofitable with a net margin of -10.7% and an EPS of -1.30. The stock has a market cap of $5.6 billion and has seen one retail post on social media in the last 24 hours.
What To Watch
MiniMed’s updated fiscal 2027 guidance and product milestones will remain in focus. Investors should monitor the U.S. launch of Fit and continued progress in the Flex product line.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
MMED by the numbers
Last: $22.42Session: +10.66%7 sessions: +19.16%Coverage: 16 stories / 9 sourcesAI sentiment: 60/100 (bullish)Mkt cap: $5.6B52w: $10.65 to $20.88
The headlines behind the move
11d agoThe FlyBULLISH 61Analyst
MiniMed price target raised to $26 from $22 at Wells Fargo
11d agoStocktwits NewsBULLISH 63Product/PR
These 2 Stocks Hit New Milestones Today – What’s Driving Retail Enthusiasm?
MiniMed’s first-quarter sales rose 17% to $843 million, while BTIG upgraded Tidewater to ‘Buy’ from ‘Neutral’.
11d agoInvesting.com Analyst RatingsBULLISH 61Analyst
BTIG raises MiniMed Group stock price target on pipeline progress
BTIG raises MiniMed Group stock price target on pipeline progress
11d agoThe FlyBULLISH 61General
MiniMed rises 11.3%
11d agoThe FlyBULLISH 67Earnings
MiniMed jumps after upping fiscal 2027 organic growth outlook
11d agoSeeking AlphaBULLISH 73Earnings
MiniMed projects ~10.5% fiscal 2027 organic revenue growth as Flex expands and Fit targets U.S. launch by summer 2027
MiniMed (MMED) Q1 FY2027 earnings call: 16% organic growth, Flex launch momentum, CE Mark win, Fit 510(k) filed, guidance raised.
11d agoMorningstarBULLISH 67Earnings
MiniMed Shares Gain as 1Q Sales Jump
Chief Executive Que Dallara called the quarter an excellent start to the fiscal year. "As our ecosystem continues to come together, we are well positioned to accelerate growth, strengthen our leadership in automated insulin delivery, and create long-term shareholder value," she added.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on MMED: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier MMED move explainers: 2026-09-02 · 2026-09-01 · 2026-08-26 · 2026-08-25